The Spatial Biology Company™

Akoya Launches Two New, Fully Optimized PD-1/PD-L1 Panels for Immuno-Oncology Biomarker Analysis of Melanoma and Lung Cancer

Akoya expands solutions for translational immuno-oncology analysis, with two new Opal™ MOTiF-based kits for deep tissue profiling of the tumor microenviroment with clinically-relevant biomarkers, including PD-1 and PD-L1, in Melanoma and Lung Cancer samples. These automation-ready staining kits include six ready-to-use primary antibodies, staining and assay reagents for analysis on the Vectra® Polaris™.  The new kits were presented at the 2019 Society for Immunotherapy of Cancer (SITC) annual meeting at the Akoya workshop and multiple poster presentations. Click here to read the full announcement. An overview of the new panels will be presented in a live webinar on Tuesday, December 17th. Click here to register for the webinar.